BAUSCH & LOMB AMERICAS INC.

Bausch & Lomb Americas Inc. specializes in the manufacturing and supply of pharmaceutical preparations, with deep expertise in the production of prescription drugs, hematology-related therapeutics, and specialty pharmaceuticals for federal healthcare systems. The company’s technical capabilities encompass GMP-compliant manufacturing processes, batch formulation, drug stability testing, and regulatory documentation for FDA-regulated products. Their focus on precision pharmaceutical manufacturing ensures consistent quality control across complex drug portfolios, including sterile injectables and oral solid dosage forms. A key differentiator is their ability to support mission-critical drug supply chains through responsive production scaling, real-time sales and reporting integration, and seamless compliance with federal procurement standards for pharmaceutical procurement. The company maintains a consistent and long-standing relationship with the Department of Veterans Affairs, delivering essential pharmaceuticals through Federal Supply Schedule contracts and exercising option periods to sustain uninterrupted supply. Their work with the VA centers on ensuring timely access to high-priority medications, including those used in chronic disease management, oncology support, and hematological therapies, reflecting a proven track record in meeting the VA’s clinical and logistical demands. Bausch & Lomb Americas Inc. operates primarily within NAICS 325412, which encompasses the formulation, packaging, and quality-assured production of finished pharmaceutical products. This vertical specialization positions them as a reliable manufacturer for government agencies requiring compliant, scalable, and traceable drug production—particularly for high-volume, low-margin therapeutics critical to public health programs. As a 2L entity headquartered in Bridgewater, New Jersey, the company operates as a corporate division within a larger enterprise structure. While no specific government certifications are listed, their consistent award history demonstrates adherence to federal quality and regulatory frameworks. Their geographic presence and operational focus are aligned with federal pharmaceutical procurement networks, reinforcing their role as a trusted supplier within the U.S. government’s healthcare supply ecosystem.